KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Inventory (2016 - 2025)

Nu Skin Enterprises' Inventory history spans 17 years, with the latest figure at $178.6 million for Q4 2025.

  • For Q4 2025, Inventory fell 6.1% year-over-year to $178.6 million; the TTM value through Dec 2025 reached $178.6 million, down 6.1%, while the annual FY2025 figure was $178.6 million, 6.1% down from the prior year.
  • Inventory for Q4 2025 was $178.6 million at Nu Skin Enterprises, roughly flat from $178.5 million in the prior quarter.
  • Across five years, Inventory topped out at $415.2 million in Q3 2021 and bottomed at $178.5 million in Q3 2025.
  • The 5-year median for Inventory is $309.3 million (2022), against an average of $298.1 million.
  • The largest annual shift saw Inventory surged 53.6% in 2021 before it plummeted 34.45% in 2024.
  • A 5-year view of Inventory shows it stood at $399.9 million in 2021, then decreased by 13.44% to $346.2 million in 2022, then dropped by 19.12% to $280.0 million in 2023, then plummeted by 32.05% to $190.2 million in 2024, then dropped by 6.1% to $178.6 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Inventory are $178.6 million (Q4 2025), $178.5 million (Q3 2025), and $180.4 million (Q2 2025).